Soru

Zorluk: OrtaNeurocognitive Disorders

An 81-year-old man is brought to the primary care clinic by his son due to a 9-month history of gradual memory decline. The son reports that the patient frequently repeats questions, has stopped managing his own finances, and recently got lost while walking in his familiar neighborhood. The patient has a history of hypertension and osteoarthritis. Vital signs are within normal limits, and the physical examination is unremarkable. After completing a thorough clinical history and medication review, arrange the following steps in the diagnostic evaluation of this patient's suspected neurocognitive disorder in the most appropriate chronological order, from the immediate next step to advanced workup.

  1. 1Administer a standardized objective cognitive assessment (e.g., Montreal Cognitive Assessment).
  2. 2Draw blood for targeted laboratory evaluation, including TSH and vitamin B12.
  3. 3Obtain a structural neuroimaging study (e.g., MRI of the brain).
  4. 4Consider functional neuroimaging (e.g., FDG-PET) or cerebrospinal fluid biomarker testing.

Cevap

The correct sequential workup for suspected neurocognitive disorder begins with objective cognitive screening, followed by laboratory testing for reversible causes, structural neuroimaging, and finally, advanced testing (such as PET or CSF biomarkers) only if the diagnosis remains atypical or unclear.
The standard diagnostic pathway for a new presentation of cognitive decline requires confirming the deficit clinically first (using a tool like the MoCA), then ruling out reversible systemic causes (with basic labs like TSH and B12), followed by ruling out structural brain lesions (with an MRI or CT). Advanced functional or biomarker testing is only pursued if these initial steps do not yield a clear clinical picture.

Adım Adım Çözüm

1
Identify the need for objective verification of the reported cognitive decline.
Standardized cognitive assessment (e.g., MoCA) is selected as the immediate next step.
Subjective reports from family must be quantified and objectively documented before initiating a medical workup.
2
Determine the initial medical workup to rule out reversible etiologies.
Targeted laboratory tests (TSH, B12, CMP, CBC) are ordered.
Metabolic and endocrine abnormalities must be excluded as they can mimic or exacerbate major neurocognitive disorders.
3
Select the appropriate initial imaging modality.
Structural MRI of the brain is ordered.
Structural imaging is a standard part of the dementia workup to rule out macroscopic intracranial pathology like strokes, masses, or hydrocephalus.
4
Determine the role of advanced diagnostic modalities.
Functional imaging or CSF biomarkers are reserved for the end of the pathway.
These tests are expensive, invasive, or specialized, and are only indicated if the standard sequential workup is inconclusive.

Anahtar Kavram

Sequential Diagnostic Evaluation of Major Neurocognitive Disorder
Bu soruyu puanla